Publications

Mahlakõiv T, Artis D.  2016.  Allergen Exposure: When Timing Is Everything.. Immunity. 45(6):1188-1190.

Flamar A-L, Klose CSN, Moeller JB, Mahlakõiv T, Bessman NJ, Zhang W, Moriyama S, Stokic-Trtica V, Rankin LC, Putzel GGarbès et al..  2020.  Interleukin-33 Induces the Enzyme Tryptophan Hydroxylase 1 to Promote Inflammatory Group 2 Innate Lymphoid Cell-Mediated Immunity.. Immunity.

Nagashima H, Mahlakõiv T, Shih H-Y, Davis FP, Meylan F, Huang Y, Harrison OJ, Yao C, Mikami Y, Urban JF et al..  2019.  Neuropeptide CGRP Limits Group 2 Innate Lymphoid Cell Responses and Constrains Type 2 Inflammation.. Immunity.

Klose CSN, Mahlakõiv T, Moeller JB, Rankin LC, Flamar A-L, Kabata H, Monticelli LA, Moriyama S, Putzel GGarbès, Rakhilin N et al..  2017.  The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation.. Nature. 549(7671):282-286.

Wallrapp A, Riesenfeld SJ, Burkett PR, Abdulnour R-EE, Nyman J, Dionne D, Hofree M, Cuoco MS, Rodman C, Farouq D et al..  2017.  The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation.. Nature. 549(7672):351-356.

Kabata H, Flamar A-L, Mahlakõiv T, Moriyama S, Rodewald H-R, Ziegler SF, Artis D.  2020.  Targeted deletion of the TSLP receptor reveals cellular mechanisms that promote type 2 airway inflammation.. Mucosal Immunol.